506365
CHEMOPH
Invest Now
Start SIP in
CHEMOPH
Performance
- Low
- ₹118
- High
- ₹128
- 52 Week Low
- ₹55
- 52 Week High
- ₹154
- Open Price₹120
- Previous Close₹124
- Volume1,756
Investment Returns
- Over 1 Month + 1.61%
- Over 3 Month + 90.33%
- Over 6 Month + 65.29%
- Over 1 Year + 56.17%
Smart Investing Starts Here Start SIP with Chemo Pharma Laboratories for Steady Growth!
Chemo Pharma Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 48.4
- PEG Ratio
- -0.7
- Market Cap Cr
- 19
- P/B Ratio
- 1.5
- Average True Range
- 5.86
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 3.66
- RSI
- 51.15
- MFI
- 32.24
Chemo Pharma Laboratories Financials
Chemo Pharma Laboratories Technicals
EMA & SMA
Current Price
₹126.00
+
1.55
(1.25%)

-
- Bearish Moving Average 8
-
- Bullish Moving Average 8
- 20 Day
- ₹126.89
- 50 Day
- ₹117.99
- 100 Day
- ₹106.90
- 200 Day
- ₹94.22
Resistance and Support
124.1
- R3 139.60
- R2 133.80
- R1 129.90
- S1 120.20
- S2 114.40
- S3 110.50
Chemo Pharma Laboratories Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-04-16 | Others | Inter-alia, to consider 1. Appointment of an Additional Director's to be designated as Managing Director & Chief Executive Officer and Non-Executive Independent Director's. 2 . Other business matters. |
2025-01-27 | Quarterly Results | |
2024-10-28 | Quarterly Results | |
2024-07-29 | Quarterly Results & A.G.M. | |
2024-05-27 | Audited Results |
Chemo Pharma Laboratories F&O
About Chemo Pharma Laboratories
- NSE Symbol
- CHEMOPH
- BSE Symbol
- 506365
- ISIN
- INE320M01019
Similar Stocks to Chemo Pharma Laboratories
Chemo Pharma Laboratories FAQs
Chemo Pharma Laboratories share price is ₹126 As on 14 May, 2025 | 20:24
The Market Cap of Chemo Pharma Laboratories is ₹18.9 Cr As on 14 May, 2025 | 20:24
The P/E ratio of Chemo Pharma Laboratories is 48.4 As on 14 May, 2025 | 20:24
The PB ratio of Chemo Pharma Laboratories is 1.5 As on 14 May, 2025 | 20:24
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.